Intravitreal faricimab for neovascular age-related macular degeneration previously treated with traditional anti-VEGF compounds: a real-world prospective study

被引：0
|
作者：
Gabriela Grimaldi
Giuseppe Cancian
Angelica Rizzato
Alex Casanova
Kathrin Perruchoud-Ader
Michele Clerici
Andrea Consigli
Moreno Menghini
机构：
[1] Ente Ospedaliero Cantonale (EOC),Department of Ophthalmology, Institute of Clinical Neurosciences of Southern Switzerland (INSI)
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2024年 / 262卷
关键词：
Faricimab; Age-related macular degeneration; Treat-and-extend; Real-world data;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1151 / 1159
页数：8
相关论文
共 50 条
  • [1] Intravitreal faricimab for neovascular age-related macular degeneration previously treated with traditional anti-VEGF compounds: a real-world prospective study
    Grimaldi, Gabriela
    Cancian, Giuseppe
    Rizzato, Angelica
    Casanova, Alex
    Perruchoud-Ader, Kathrin
    Clerici, Michele
    Consigli, Andrea
    Menghini, Moreno
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (04) : 1151 - 1159
  • [2] Intravitreal faricimab for treatment naïve patients with neovascular age-related macular degeneration: a real-world prospective study
    Grimaldi, Gabriela
    Cancian, Giuseppe
    Paris, Arianna
    Clerici, Michele
    Volpe, Giulio
    Menghini, Moreno
    [J]. INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2024, 10 (01)
  • [3] Real-world efficacy of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review
    Nasimi, Nasratullah
    Nasimi, Safiullah
    Grauslund, Jakob
    Vergmann, Anna Stage
    Subhi, Yousif
    [J]. INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2024, 10 (01)
  • [4] Switching intravitreal anti-VEGF treatment in neovascular age-related macular degeneration
    Kucukerdonmez, Cem
    Gelisken, Faik
    Yoeruek, Efdal
    Bartz-Schmidt, Karl Ulrich
    Leitritz, Martin Alexander
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2015, 25 (01) : 51 - 56
  • [5] The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF
    Han, Fangyuan
    Chen, Xingwang
    Zhao, Ruyi
    Jin, Xin
    Tan, Wei
    Zhang, Ying
    [J]. BMC OPHTHALMOLOGY, 2022, 22 (01)
  • [6] The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF
    Fangyuan Han
    Xingwang Chen
    Ruyi Zhao
    Xin Jin
    Wei Tan
    Ying Zhang
    [J]. BMC Ophthalmology, 22
  • [7] The Real-World Efficacy and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study
    Aziz, Aamir Abdul
    Khan, Hannah
    Abbey, Ashkan Michael
    Almeida, David R. P.
    Avery, Robert L.
    Banda, Himanshu K.
    Barakat, Mark
    Bhandari, Ramanath
    Chang, Emmanuel Y.
    Haug, Sara
    London, Nikolas J. S.
    Sheth, Veeral
    Wolfe, Jeremy
    Singer, Michael Andrew
    Danzig, Carl J.
    Khanani, Arshad M.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [8] Early real-world outcomes in patients with neovascular Age-related Macular Degeneration (nAMD) treated with Faricimab
    Raslan, Walid
    Younis, Saad
    Fabozzi, Lorenzo
    Hassan, Islam
    Palmieri, Filomena
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [9] Neovascular age-related macular degeneration and anti-VEGF nonresponders
    Sheybani, Arsham
    Almony, Arghavan
    Blinder, Kevin J.
    Shah, Gaurav K.
    [J]. EXPERT REVIEW OF OPHTHALMOLOGY, 2010, 5 (01) : 35 - 41
  • [10] VEGF levels in serum and the outcome of intravitreal anti-VEGF treatment in neovascular age-related macular degeneration
    Abedi, Farshad
    Wickremasinghe, Sanjeewa
    Islam, Amirul
    Guymer, Robyn H.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
12345